DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Märten A, Schmidt J, Debus J. et al
CapRI: Final results of the open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon-α2b (CRI) versus 5-FU alone for patients with resected pancreatic adenocarcinoma (PAC).
Proc Am Soc Clin Oncol 2010; 28: abstract LBA4012-
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.